Taro Kuritani

Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease

Kazuyuki Yoshizaki, Tadashi Matsuda, Naoki Nishimoto et al. · Blood · 1989 · 899 citations

T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF.

Atsushi Muraguchi, Tadamitsu Kishimoto, Yukio Miki et al. · The Journal of Immunology · 1981 · 240 citations

Trf Activity, Lymphocyte Development, Adaptive Immune System +22

Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.

Norihiro Nishimoto, Kazuyuki Yoshizaki, Keiji Maeda et al. · PubMed · 2003 · 205 citations

In vitro immune response of human peripheral lymphocytes. I. The mechanism(s) involved in T cell helper functions in the pokeweed mitogen-induced differentiation and proliferation of B cells.

Toshio Hirano, Taro Kuritani, Tadamitsu Kishimoto et al. · PubMed · 1977 · 133 citations

Lymphocyte Development, Pwm-stimulated Pbl, T-regulatory Cell +19

IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.

Mitsufumi Mayumi, Taro Kuritani, Hiromi Kubagawa et al. · The Journal of Immunology · 1983 · 120 citations · Full text

Igg Subclass Expression, Plasma Cells, Autoimmune Disease +15